Kwan, Antonia
Genentech
4 papers on CoChatORCID 0009-0004-1825-2422
Most cited papers
- Verified
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies
Sehn, L. H., Bartlett, N. L., Matasar, M. J., Schuster, S. J., Assouline, S. E., Giri, P., Kuruvilla, J., Shadman, M., Cheah, C. Y., Dietrich, S., et al. (2025) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 94
- Verified
Polygenic risk for skin autoimmunity impacts immune checkpoint blockade in bladder cancer
Khan, Z., Di Nucci, F., Kwan, A., Hammer, C., Mariathasan, S., Rouilly, V., Carroll, J., Fontes, M., Ley Acosta, S., Guardino, E., et al. (2020) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 91
- Verified
Population Pharmacokinetics and Exposure-Response Analyses for Glofitamab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Confirmation of Efficacy and CRS Mitigation in Patients with Step-up Dosing
Djebli, N., Morcos, P. N., Jaminion, F., Guerini, E., Kratochwil, N. A., Justies, N., Schick, E., Kwan, A., Humphrey, K., Lundberg, L., et al. (2020) · Blood
Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research
Cited by 16
- Verified
Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma
Li, C.-C., Bender, B., Yin, S., Li, Z., Zhang, C., Hernandez, G., Kwan, A., Sun, L., Adamkewicz, J. I., Wang, H., et al. (2019) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free